Daniel Vitt - 04 Jun 2025 Form 4/A - Amendment Insider Report for IMMUNIC, INC. (IMUX)

Signature
/s/ Daniel Vitt
Issuer symbol
IMUX
Transactions as of
04 Jun 2025
Transactions value $
$11,550
Form type
4/A - Amendment
Filing time
20 Jun 2025, 17:15:45 UTC
Date Of Original Report
06 Jun 2025
Previous filing
06 Dec 2024
Next filing
18 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vitt Daniel CEO and Director, Director 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK /s/ Daniel Vitt 20 Jun 2025 0001773673

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMUX Common Stock Purchase $11.6K +15K +107.14% $0.77 29K 04 Jun 2025 Direct F1
holding IMUX Common Stock 363K 04 Jun 2025 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Award $0 +1.56M $0.00 1.56M 05 Jun 2025 Common Stock 1.56M $0.77 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
F2 362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
F3 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.

Remarks:

This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Peron on June 6, 2025 to correct an administrative error that incorrectly reported the number of stock options granted.